Recent Quotes (30 days)

You have no recent quotes
chg | %

Premaitha Health PLC news

   Watch this stock
Showing stories 1 - 10 of about 68   

Articles published

NIPT 11.12 +0.38 (3.49%)
price chart
Premaitha Health
RNS Number: 6794K Premaitha Health PLC 23 September 2016 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Premaitha Health plc 2 Reason ...
Premaitha Health PLC Premaitha Health signs Investment Agreement with Thermo ...
Premaitha's CE-marked, non-invasive prenatal screening (NIPT) product, the IONA� test, runs on Thermo Fisher's two sequencing instruments, the Ion Proton and Ion Chef.
Premaitha Health PLC (NIPT.L)
Premaitha Health PLC, a molecular diagnostic company, develops tests for non-invasive prenatal screening and other applications in the United Kingdom.
finnCap reiterated Premaitha Health Plc (LON:NIPT) as 'Corporate' With 20 PT
Premaitha Health PLC, formerly ViaLogy plc, is engaged in molecular diagnostics business for research, and the development and commercialization of gene analysis techniques.
Premaitha Health PLC 90.5% Potential Upside Indicated by finnCap  DirectorsTalk Interviews
Premaitha Health PLC 131.7% Potential Upside Indicated by finnCap
Premaitha Health PLC using EPIC/TICKER code LON:NIPT had its stock rating noted as 'Initiates/Starts' with the recommendation being set at 'CORPORATE' this morning by analysts at finnCap.
SMALL CAP IDEAS: Premaitha Health builds foundations for successful European ...
Very often investors are asked to commit to the long haul when they buy into the latest new thing in the healthcare sector.
Premaitha Health to join AIM as it prepares to launch first product
Subject to ViaLogy shareholders approval later this month, the enlarged business will be re-named Premaitha Health PLC and will become a listed company on the AIM platform.
ViaLogy Buys Molecular Diagnostic Company  London South East
Related articles »  
Premaitha Health PLC's (NIPT) Corporate Rating Reaffirmed at FinnCap
Premaitha Health PLC logo Premaitha Health PLC (LON:NIPT)'s stock had its “corporate” rating restated by FinnCap in a report issued on Monday.
Premaitha Health (LON:NIPT) New Price Targets
Premaitha Health PLC, formerly ViaLogy plc, is engaged in molecular diagnostics business for research, and the development and commercialization of gene analysis techniques.
Outstanding Analyst Ratings For Premaitha Health (LON:NIPT)
Premaitha Health PLC, formerly ViaLogy plc, is engaged in molecular diagnostics business for research, and the development and commercialization of gene analysis techniques.